Global Plasmapheresis Periprocedural Care Equipments Market – Industry Trends and Forecast to 2029

Plasmapheresis Periprocedural Care Equipments Market Analysis and Size

A semipermeable membrane-based device in conjunction with hemodialysis apparatus can be used to perform plasmapheresis. The greater flow rates of membrane-based plasmapheresis equipment, which range from 100 to 150 mL/min as opposed to 50 to 70 mL/min for centrifuge-based equipmentin which central lines are necessary as opposed to peripheral lines.

Data Bridge Market Research analyses that the plasmapheresis periprocedural care equipments market which is expected to undergo a CAGR of 5.20% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Plasmapheresis Periprocedural Care Equipments Market Scope and Segmentation      

Market Definition

The word "plasmapheresis" is used to describe a wide variety of techniques where extracorporeal separation of blood components yields a filtered plasma product. Centrifugation or the application of semipermeable membranes are two methods for separating plasma from whole blood.

Global Plasmapheresis Periprocedural Care Equipments Market Dynamics

Drivers

• Increasing incidence of blood related disorders

Many blood diseases and disorders are caused by genes. Hematologic diseases include rare genetic disorders, anemia, HIV, sickle cell disease. This will boost the market growth.

Furthermore, increasing health care expenditure coupled with rise in global per capita income is expected to have a significant impact on the plasmapheresis periprocedural care equipments market in the forecast period of 2022 to 2029.

• Rising government reimbursement programs 

The "Radiology Cares, The Art of Patient-centered Practice" campaign was introduced by the Radiological Society of North America (RSNA) in 2012. This programme was created to support radiologists in improving patients' experiences throughout their radiologic care and to draw attention to the significant contribution radiologists make to patients' overall health.

Opportunities

• Rising disorders associated with therapeutic plasmapheresis

Many disorders can be treated with therapeutic plasmapheresis. A toxic substance that can be filtered such as immunoglobulin, is present in the plasma under the conditions. The Apheresis Applications Committee of the American Society for Apheresis has divided the illnesses that can be treated with therapeutic plasmapheresis into four groups (ASFA). Category 1 includes disorders where plasmapheresis can be used as a first-line treatment, category 2 includes disorders where plasmapheresis can be used as a second-line treatment in addition to the current standard of care, category 3 includes disorders where there is little evidence of a benefit from plasmapheresis and therapy must be customised, and category 4 includes disorders where the evidence suggests that plasmapheresis is either ineffective or harmful.

Restraints/Challenges

On the other hand, the lack of donor availability and histocompatibility and high risks coupled with apheresis devices will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the plasmapheresis periprocedural care equipments market.

This plasmapheresis periprocedural care equipments market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the plasmapheresis periprocedural care equipments market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Plasmapheresis Periprocedural Care Equipments Market Scope

The plasmapheresis periprocedural care equipments market is segmented on the basis of product, application, technology, procedure and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Disposable Apheresis Kits
• Apheresis Machines

 Application

• Renal Disease
• Neurology
• Hematology

Technology

• Membrane filtration
• Centrifugation

 Procedure

• Photopheresis
• LDL Apheresis
• Plateletpheresis
• Leukapheresis
• Erythrocytapheresis

 End Use

• Hospitals and Clinics
• Biopharmaceutical Companies
• Others

Plasmapheresis Periprocedural Care Equipments Market Regional Analysis/Insights

The plasmapheresis periprocedural care equipments market is analysed and market size insights and trends are provided by country, product, application, technology, procedure and end use as referenced above.

The countries covered in the plasmapheresis periprocedural care equipments market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the plasmapheresis periprocedural care equipments market due to the rising awareness amongst doctors in the region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and growing demand of advanced medical technology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Plasmapheresis Periprocedural Care Equipments Market Share Analysis

The plasmapheresis periprocedural care equipments market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to plasmapheresis periprocedural care equipments market.

Some of the major players operating in the plasmapheresis periprocedural care equipments market are:

• Asahi Kasei Kuraray Medical Co Ltd (Japan)
• Terumo BCT Inc. (U.K.)
• Fenwal (U.S.)
• Haemonetics Corporation (U.S.)
• Octapharma AG (Switzerland)
• Therakos Ltd. (U.S.)
• Grifols, S.A. (Spain)
• B. Braun Melsungen AG (Germany)
• Hemacare Corporation (U.S.)
• Kawasumi Laboratories (Japan)
• Fresenius Kabi AG (Germany)

SKU-55094